NCT04116385View on ClinicalTrials.gov

Evaluation of the Quantra System in a Surgical Oncological Population

CompletedOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

July 30, 2020

Conditions

Blood Loss, Surgical

Interventions

DIAGNOSTIC_TEST

Quantra System

Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

HemoSonics LLC

INDUSTRY

NCT04116385 - Evaluation of the Quantra System in a Surgical Oncological Population | Biotech Hunter | Biotech Hunter